Compare Amphastar Pharmaceuticals Inc (AMPH) vs Palo Alto Networks Inc (PANW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Palo Alto Networks Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while Palo Alto Networks Inc trades at $383.79 (market cap $313.81B). The key difference: Palo Alto Networks Inc is far larger — about 363.2× Amphastar Pharmaceuticals Inc's market cap, and Palo Alto Networks Inc is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | PANW | |
|---|---|---|
Market Cap | $863.95M | $313.81B |
Sector | Health | Technology |
52-Week High | $30.81 | $385.04 |
52-Week Low | $16.87 | $141.67 |
Enterprise Value | $1.26B | $312.77B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
Palo Alto Networks (PANW) trades at $363.86, up 1.22% today, near its pivot point of $365. The stock shows strong bullish momentum with consistent earnings beats and robust revenue growth, reaching $9.22 billion in fiscal 2025. Technical indicators signal bullish trends, while high valuation ratios like a P/E of 316.4 reflect market optimism. Recent news highlights AI-driven cybersecurity demand and record stock performance following industry events.
Outlook remains positive due to AI security tailwinds and earnings strength, but risks include premium valuation, integration costs from acquisitions, and regulatory scrutiny in China. Analyst consensus is strongly bullish with a $344.94 price target, though current price exceeds this, suggesting cautious optimism for growth-driven upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Palo Alto Networks Inc
Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →
